In individuals who are deficient in CYP2D6, coadministration of modafinil with substrates of CYP2D6 that have ancillary routes of elimination by way of CYP2C19 (eg, tricyclic antidepressants and selective serotonin reuptake inhibitors) may possibly bring on elevated circulating amounts of these medicines and demand dose adjustment (Robertson et al